SCHEMBL6352018

SCHEMBL6352018

COC(=O)c1cc(Br)ccc1NC(=O)c1cccc(C(=O)c2ccccc2)c1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.66
ALDH1A1 P00352 3/20 0.60
GAA P10253 1/20 0.60
AKR1C2 P52895 3/20 0.58
AKR1C1 Q04828 3/20 0.58
AKR1C4 P17516 1/20 0.58
AKR1C3 P42330 1/20 0.58
MAPK1 P28482 3/20 0.53
KDM4E B2RXH2 1/20 0.53
HSD17B10 Q99714 1/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
ABL1 P00519 1/20 0.52
TSHR P16473 1/20 0.52
RIN1 Q13671 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
LMNA P02545 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.51
HTT P42858 1/20 0.51
NPSR1 Q6W5P4 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31454340 0.90 MAPT (0.72) MAPTALDH1A1GAAAKR1C2AKR1C1
SCHEMBL14075415 0.90 MAPT (0.72) MAPTALDH1A1GAAAKR1C2AKR1C1
SCHEMBL6349757 0.87 AKR1C2 (0.76) MAPTAKR1C2AKR1C1AKR1C4AKR1C3
SCHEMBL6352639 0.85 ALDH1A1 (0.55) MAPTALDH1A1GAAAKR1C2AKR1C1
SCHEMBL6352643 0.85 ALDH1A1 (0.55) MAPTALDH1A1GAAAKR1C2AKR1C1
SCHEMBL266398 0.81 AKR1C2 (0.54) MAPTALDH1A1GAAAKR1C2AKR1C1
SCHEMBL6357922 0.79 MAPT (0.81) MAPTALDH1A1AKR1C2AKR1C1AKR1C4
SCHEMBL2275624 0.79 KDM4E (0.64) MAPTALDH1A1GAAMAPK1KDM4E
SCHEMBL418984 0.79 GRIK1 (0.64) MAPTALDH1A1GAAAKR1C2AKR1C1
SCHEMBL235942 0.77 MAPT (0.59) MAPTALDH1A1GAAAKR1C3MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US disclosed
WO-2004018414-A2 ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 MAPT 4753/4885ALDH1A1 462/4885GAA 171/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.